[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":130300000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":18600000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":20700000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":3400000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":200000.0,"MarketableSecuritiesCurrent_0_Q1_USD":669300000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":70100000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":30800000.0,"OtherLiabilitiesCurrent_0_Q1_USD":45000000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":50000000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":868000000.0,"OtherAssetsCurrent_0_Q1_USD":60200000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":10200000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":43800000.0,"EarningsPerShareDiluted_1_Q1_USD":3.12,"ProceedsFromStockOptionsExercised_1_Q1_USD":700000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":137700000.0,"InvestmentIncomeInterest_1_Q1_USD":10000000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":12400000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":246100000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":10700000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":148400000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":1000000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2068400000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":1495900000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q1_USD":645500000.0,"TreasuryStockCommonShares_0_Q1_shares":26619216.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":2500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":356300000.0,"ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_1_Q1_USD":13200000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":451400000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":2500000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":479200000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":3400000.0,"OtherNoncashIncomeExpense_1_Q1_USD":22800000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":200000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-500000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":10200000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"LongTermLineOfCredit_0_Q1_USD":800000000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":28100000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":20100000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-61900000.0,"GoodwillGross_0_Q1_USD":28000000.0,"CumulativeEffectOnRetainedEarningsNetOfTax1_1_Q1_USD":-800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":136800000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":1513500000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q1_USD":641300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":43900000.0,"OtherAssetsNoncurrent_0_Q1_USD":168000000.0,"NonoperatingIncomeExpense_1_Q1_USD":4900000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":13000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":214600000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-27600000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-50200000.0,"LiabilitiesCurrent_0_Q1_USD":207300000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":4025900000.0,"Liabilities_0_Q1_USD":1077400000.0,"InventoryNet_0_Q1_USD":92000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-1700000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":33900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":171600000.0,"CostsAndExpenses_1_Q1_USD":189600000.0,"CommonStockValue_0_Q1_USD":700000.0,"CommonStockSharesOutstanding_0_Q1_shares":44002068.0,"CommonStockSharesIssued_0_Q1_shares":70621284.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":875200000.0,"AssetsCurrent_0_Q1_USD":1846300000.0,"Assets_0_Q1_USD":4025900000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7600000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-3500000.0,"AccountsReceivableNetCurrent_0_Q1_USD":149600000.0,"ProfitLoss_1_Q1_USD":137700000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":739200000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":3462100000.0,"Revenues_1_Q1_USD":356300000.0,"Goodwill_0_Q1_USD":28000000.0,"EarningsPerShareBasic_1_Q1_USD":3.14,"CostOfGoodsAndServicesSold_1_Q1_USD":23400000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":5400000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":8700000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-6100000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-18800000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.2,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":44100000.0,"TreasuryStockCommonValue_0_Q1_USD":2579200000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":700000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":73200000.0,"OperatingIncomeLoss_1_Q1_USD":166700000.0,"InterestPaidNet_1_Q1_USD":7500000.0,"InterestExpense_1_Q1_USD":8200000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":158300000.0,"IncomeTaxesPaidNet_1_Q1_USD":-8700000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5300000.0,"CommonStockSharesAuthorized_0_Q1_shares":245000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"StockholdersEquity_0_Q1_USD":2948500000.0,"ShareBasedCompensation_1_Q1_USD":30800000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200429"}]